Kocaba V - Search Results

1

Cultured Cells and ROCK Inhibitor for Bullous Keratopathy.

Wahlig S, Kocaba V, Mehta JS. Wahlig S, et al. Among authors: kocaba v. N Engl J Med. 2018 Sep 20;379(12):1184. doi: 10.1056/NEJMc1805808. N Engl J Med. 2018. PMID: 30260152 No abstract available.

2

Quantification of the Posterior Cornea Using Swept Source Optical Coherence Tomography.

Wahlig S, Yam GH, Chong W, Seah XY, Kocaba V, Ang M, Htoon HM, Tun TA, Ong HS, Mehta JS. Wahlig S, et al. Among authors: kocaba v. Transl Vis Sci Technol. 2018 Sep 4;7(5):2. doi: 10.1167/tvst.7.5.2. eCollection 2018. Transl Vis Sci Technol. 2018. PMID: 30197834 Free PMC article.

3

Trinucleotide repeat expansion length as a predictor of the clinical progression of Fuchs' Endothelial Corneal Dystrophy.

Soh YQ, Peh Swee Lim G, Htoon HM, Gong X, Mootha VV, Vithana EN, Kocaba V, Mehta JS. Soh YQ, et al. Among authors: kocaba v. PLoS One. 2019 Jan 25;14(1):e0210996. doi: 10.1371/journal.pone.0210996. eCollection 2019. PLoS One. 2019. PMID: 30682148 Free PMC article.

4

The future of keratoplasty: cell-based therapy, regenerative medicine, bioengineering keratoplasty, gene therapy.

Mehta JS, Kocaba V, Soh YQ. Mehta JS, et al. Among authors: kocaba v. Curr Opin Ophthalmol. 2019 Jul;30(4):286-291. doi: 10.1097/ICU.0000000000000573. Curr Opin Ophthalmol. 2019. PMID: 31045881 Review.

5

Fuchs endothelial corneal dystrophy and corneal endothelial diseases: East meets West.

Soh YQ, Kocaba V, Pinto M, Mehta JS. Soh YQ, et al. Among authors: kocaba v. Eye (Lond). 2020 Mar;34(3):427-441. doi: 10.1038/s41433-019-0497-9. Epub 2019 Jul 2. Eye (Lond). 2020. PMID: 31267087 Free PMC article. Review.

6

Characterization of Human Transition Zone Reveals a Putative Progenitor-Enriched Niche of Corneal Endothelium.

Yam GH, Seah X, Yusoff NZBM, Setiawan M, Wahlig S, Htoon HM, Peh GSL, Kocaba V, Mehta JS. Yam GH, et al. Among authors: kocaba v. Cells. 2019 Oct 12;8(10):1244. doi: 10.3390/cells8101244. Cells. 2019. PMID: 31614883 Free PMC article.

7

A prognostic biomarker of corneal repair.

Mehta JS, Kocaba V, Peh GS. Mehta JS, et al. Among authors: kocaba v. Nat Biomed Eng. 2019 Dec;3(12):945-946. doi: 10.1038/s41551-019-0488-y. Nat Biomed Eng. 2019. PMID: 31811266 No abstract available.

8

Peroxiredoxin-1 regulates lipid peroxidation in corneal endothelial cells.

Lovatt M, Adnan K, Kocaba V, Dirisamer M, Peh GSL, Mehta JS. Lovatt M, et al. Among authors: kocaba v. Redox Biol. 2020 Feb;30:101417. doi: 10.1016/j.redox.2019.101417. Epub 2019 Dec 30. Redox Biol. 2020. PMID: 31901729 Free PMC article.

9

A Novel Approach of Harvesting Viable Single Cells from Donor Corneal Endothelium for Cell-Injection Therapy.

Ong HS, Peh G, Neo DJH, Ang HP, Adnan K, Nyein CL, Morales-Wong F, Bhogal M, Kocaba V, Mehta JS. Ong HS, et al. Among authors: kocaba v. Cells. 2020 Jun 9;9(6):1428. doi: 10.3390/cells9061428. Cells. 2020. PMID: 32526886 Free PMC article.

10

Corneal dystrophies.

Soh YQ, Kocaba V, Weiss JS, Jurkunas UV, Kinoshita S, Aldave AJ, Mehta JS. Soh YQ, et al. Among authors: kocaba v. Nat Rev Dis Primers. 2020 Jun 11;6(1):46. doi: 10.1038/s41572-020-0178-9. Nat Rev Dis Primers. 2020. PMID: 32528047 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page